There is a desperate need to infuse SNFs with more resources, not only in terms of personal protective equipment, but also the critical infection prevention resources and staffing.
Since the beginning of the SARS-CoV-2/COVID-19 pandemic in the United States, we have widely known the vulnerability of certain patient populations. Early on, skilled nursing facilities and other long-term care facilities began to show a propensity for transmission of the viral infection.
From limited infection prevention resources to vulnerable patient populations and often staff stretched thin, these environments showed promise for the disease to take hold. While we knew this would be a weak point, how many were truly infected? In the early days of the outbreak, testing was only done on those with symptoms, but as resources have increased, so has the testing availability. A new study from the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report (MMWR) evaluated the prevalence of COVID-19 in Detroit skilled nursing facilities (SNFs) from March until May of this year.
Utilizing a point prevalence survey in which all staff and residents were tested regardless of symptoms, they found deeply worrying statistics across twenty-six of Detroit’s SNFs. Testing occurred across multiple facilities based upon prioritization and was performed in conjunction with the city health department. Moreover, the researchers performed onsite infection prevention assessments and consultations—“Two follow-up IPC assessments were conducted for the 12 facilities participating in the second survey and included examination of cohorting practices using a facility floorplan, supply and use of personal protective equipment, hand hygiene practices, staffing mitigation planning, and other IPC activities.”
The local health department aided in collection of information on positive results, symptom status, hospitalizations, and fatalities. Ultimately, the researchers found that from March 7 to May 8, 44% of the 2,773 Detroit SNF residents were found to be positive for SARS-CoV-2/COVID-19. The median age for those positive residents was 72 years and 37% ended up requiring hospitalization. Unfortunately, 24% of those who tested positive, died. The authors noted that “Among 566 COVID-19 patients who reported symptoms, 227 (40%) died within 21 days of testing, compared with 25 (5%) among 461 patients who reported no symptoms; 35 (19%) deaths occurred among 180 patients for whom symptom status was unknown.”
Of the 12 facilities that participated in the second point prevalence survey, eight had enforced cohorting of positive patients in dedicated areas prior to the survey. Most facilities had a census of roughly 80 patients and of those tested during the second survey, 18% had positive results and were not known to be positive. As the authors note, this study points to the vulnerability of this patient population and the high attack rate. Across those 26 SNFs, there was an overall attack rate of 44% and a hospitalization rate related to COVID-19 of 37%. These numbers are startling and point to a continued need for early detection, infection prevention efforts, cohorting, and collaboration with local public health departments. There is a desperate need to infuse SNFs with more resources, not only in terms of personal protective equipment, but also the critical infection prevention resources and staffing. As these are vulnerable environments, continued support will be needed for not only the duration of the pandemic but well after.
Healing With Algorithms: AI's Impact on Epidemiology and Infection Control
April 2nd 2024Media in the US presents AI as both beneficial and risky. Positive coverage shows AI's potential through virtual assistants like Siri, while cautionary tales warn of misuse like misinformation and deepfakes. How does all this work in health care?
Four Years After COVID-19: What Has the Infection Prevention Community Learned?
March 15th 2024Four years ago today, March 15, 2020, the COVID-19 lockdown began, and since then, the world has undergone significant changes. It has been a terrifying experience for everyone, especially for the infection prevention community, both within and outside of the health care sector. However, a crucial question remains unanswered: What has the infection prevention community learned from this pandemic, and where does it go from here?
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.